BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36464682)

  • 21. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
    Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
    J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of surgery on survival after progression of glioblastoma: A retrospective cohort analysis of a contemporary patient population.
    Sastry RA; Shankar GM; Gerstner ER; Curry WT
    J Clin Neurosci; 2018 Jul; 53():41-47. PubMed ID: 29680441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
    De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
    Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma.
    Park CK; Kim JH; Nam DH; Kim CY; Chung SB; Kim YH; Seol HJ; Kim TM; Choi SH; Lee SH; Heo DS; Kim IH; Kim DG; Jung HW
    Neuro Oncol; 2013 Aug; 15(8):1096-101. PubMed ID: 23800677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.
    Wann A; Tully PA; Barnes EH; Lwin Z; Jeffree R; Drummond KJ; Gan H; Khasraw M
    J Neurooncol; 2018 Apr; 137(2):409-415. PubMed ID: 29294233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
    Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
    Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.
    D'Amico RS; Cloney MB; Sonabend AM; Zacharia B; Nazarian MN; Iwamoto FM; Sisti MB; Bruce JN; McKhann GM
    World Neurosurg; 2015 Oct; 84(4):913-9. PubMed ID: 26074434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
    J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of re-operation on survival in patients with recurrent glioblastoma.
    Franceschi E; Bartolotti M; Tosoni A; Bartolini S; Sturiale C; Fioravanti A; Pozzati E; Galzio R; Talacchi A; Volpin L; Morandi L; Danieli D; Ermani M; Brandes AA
    Anticancer Res; 2015 Mar; 35(3):1743-8. PubMed ID: 25750337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
    Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
    Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of subventricular zone involvement at recurrence with survival after repeat surgery in patients with recurrent glioblastoma.
    Sonoda Y; Saito R; Kanamori M; Kumabe T; Uenohara H; Tominaga T
    Neurol Med Chir (Tokyo); 2014; 54(4):302-9. PubMed ID: 24390189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
    Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
    J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
    Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
    World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence.
    Sung KS; Roh TH; Moon JH; Kim EH; Kang SG; Kim SH; Chang JH
    World Neurosurg; 2020 Mar; 135():e459-e467. PubMed ID: 31843727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.
    McNamara MG; Lwin Z; Jiang H; Templeton AJ; Zadeh G; Bernstein M; Chung C; Millar BA; Laperriere N; Mason WP
    J Neurooncol; 2014 Mar; 117(1):147-52. PubMed ID: 24469854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.